A total of 400,000 doses of the Comirnaty mRNA vaccine against COVID-19, developed by Pfizer/BioNTech, were delivered to Ukraine this month under the framework of the EU-supported COVAX Facility.
The vaccines will be distributed throughout 23 regions in the country by the Ministry of Health of Ukraine.
“With the approach of the autumn/winter period, it is especially important to protect yourself from COVID-19, because as the experience of past years shows, the incidence increases sharply at this time,” said Ihor Kuzin, Deputy Minister of Health and Chief State Sanitary Doctor of Ukraine.
Ukraine joined COVAX with the support of Team Europe, the WHO, UNICEF and other international partners. The vaccines are being delivered by the UNICEF supply department.
Find out more
News
-
Digital hub in Zaporizhzhia: what opportunities and EU support local businesses receive
-
Three Ukrainian vocational education and training colleges set to receive more than €24 million in EU-backed financing for new centres of vocational excellence
-
Strategic Thinking, Sustainable Development, and Integrity: How EU Municipalities Are Helping Ukraine Integrate into the EU
-
EU-Supported Narrow-Gauge Railway Station Museum Under Construction in Prykarpattia
-
Kyiv puts 85 new buses into service with EU support, improving daily travel for residents
-
European Investment Bank allocates €60 million for border infrastructure modernisation